Encompass Health price target raised to $116 from $108 at Truist
The Fly

Encompass Health price target raised to $116 from $108 at Truist

Truist raised the firm’s price target on Encompass Health (EHC) to $116 from $108 and keeps a Buy rating on the shares. The company reported strong Q3 results ahead of consensus estimates driven by ongoing volume momentum and solid cost management, and the firm continues to see a sizable market opportunity for Encompass, with labor trends “stable or improving”, the analyst tells investors in a research note.

Don't Miss out on Research Tools:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App